{"result": {"id": "08ec82b9-5142-448a-a7d2-f6be9bbb3cbf", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Hypertension Research and Cardiovascular Health Community\",\n    \"summary\": \"This community is centered around hypertension research and cardiovascular health, with key entities including researchers like BENETOS A and CHENG YB, journals such as CIRC RES and CIRCULATION, and organizations like the American Heart Association. These entities are interconnected through research publications, clinical trials, and collaborative studies, focusing on hypertension management, cardiovascular risks, and related health outcomes.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant contributions to understanding and managing hypertension and cardiovascular diseases, which are leading causes of morbidity and mortality worldwide.\",\n    \"findings\": [\n        {\n            \"summary\": \"Central Role of CIRCULATION and CIRC RES in Hypertension Research\",\n            \"explanation\": \"CIRCULATION and CIRC RES serve as pivotal platforms for publishing high-impact research on hypertension and cardiovascular health. CIRCULATION, in particular, has published landmark studies such as the Framingham Heart Study and the TARGET BP I trial, highlighting its role in advancing cardiovascular medicine. [Data: Entities (2152, 2810), Relationships (3077, 2961)]\"\n        },\n        {\n            \"summary\": \"BENETOS A's Contributions to Hypertension Management\",\n            \"explanation\": \"BENETOS A is a key researcher specializing in hypertension management, particularly in older and frail patients. His work contributes significantly to the broader understanding of hypertension and its management strategies, emphasizing the importance of tailored approaches for aging populations. [Data: Entities (3200), Relationships (3360)]\"\n        },\n        {\n            \"summary\": \"American Heart Association's Leadership in Cardiovascular Health\",\n            \"explanation\": \"The American Heart Association plays a central role in this community by publishing evidence-based guidelines, conducting research, and advocating for cardiovascular health. Its collaborations with other organizations and researchers underscore its influence in shaping hypertension and cardiovascular disease management practices. [Data: Entities (2475), Relationships (2668, 3281, 4455)]\"\n        },\n        {\n            \"summary\": \"Innovative Clinical Trials in Hypertension Treatment\",\n            \"explanation\": \"Clinical trials such as TARGET BP I and PRECISION represent cutting-edge research in hypertension treatment, exploring novel interventions like alcohol-mediated renal denervation and aprocitentan for resistant hypertension. These trials highlight the community's commitment to finding effective treatments for challenging cases of hypertension. [Data: Entities (2923, 2900), Relationships (3077, 3023)]\"\n        },\n        {\n            \"summary\": \"Global Efforts in Blood Pressure Screening\",\n            \"explanation\": \"Initiatives like May Measurement Month 2021 demonstrate the community's global reach, focusing on raising awareness and improving hypertension detection during the COVID-19 pandemic. These efforts highlight the importance of widespread blood pressure screening in combating hypertension. [Data: Entities (2388), Relationships (2625, 2626)]\"\n        },\n        {\n            \"summary\": \"Cross-Disciplinary Collaborations in Hypertension Research\",\n            \"explanation\": \"The community benefits from cross-disciplinary collaborations, such as those between the American Heart Association and the American College of Cardiology, and between researchers specializing in hypertension and diabetes. These collaborations enrich the community's research output and broaden its impact on public health. [Data: Relationships (3149, 3554)]\"\n        },\n        {\n            \"summary\": \"Focus on Masked Hypertension and Subtypes\",\n            \"explanation\": \"Research on masked hypertension and its subtypes, led by researchers like CHENG YB and ZHANG DY, addresses a critical gap in hypertension diagnosis and management. Their work on the association between masked hypertension subtypes and target organ damage provides valuable insights for clinical practice. [Data: Entities (2309, 2357), Relationships (3300)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751560525, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 794, "prompt_tokens": 8110, "total_tokens": 8904, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1600}, "prompt_cache_hit_tokens": 1600, "prompt_cache_miss_tokens": 6510}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n3200,BENETOS A,\"BENETOS A is a researcher and author primarily associated with studies on diabetes and hypertension, with a particular focus on hypertension management in older and frail patients. His work contributes to the broader understanding of these conditions, particularly in aging populations. The descriptions consistently highlight his involvement in research related to cardiovascular and metabolic diseases, emphasizing his expertise in hypertension and diabetes. There are no contradictions in the provided descriptions, as they collectively reinforce his role as a researcher specializing in these areas.\",5\n2810,CIRC RES,\"**CIRC RES** is a journal dedicated to publishing research on cardiovascular studies, with a particular focus on hypertension-related topics. It covers a broad range of cardiovascular research, including specialized studies on hypertension management in older patients. The journal serves as a key resource for advancements in cardiovascular medicine and hypertension treatment.\",2\n2923,TARGET BP I,TARGET BP I is a randomized clinical trial on alcohol-mediated renal denervation,3\n2152,CIRCULATION,\"**CIRCULATION** is a prominent medical journal published by the American Heart Association, specializing in cardiovascular health and diseases. It serves as a key platform for high-impact research, including clinical trials, observational studies, and advisory reports. Notable publications in *Circulation* include the **Framingham Heart Study**, which has been foundational in understanding cardiovascular risk factors, as well as the **TARGET BP I randomized clinical trial**, which investigated intensive versus standard blood pressure control and its effects on cerebrovascular outcomes. The journal has also featured studies on blood pressure trajectories in the elderly, the relationship between blood pressure and stroke recurrence, and cumulative blood pressure exposure in young adulthood. Additionally, *Circulation* published research on pharmacological interventions, such as a 2009 study examining the effects of aliskiren, losartan, or both on left ventricular mass in hypertensive patients with left ventricular hypertrophy. The journal further contributes to public health guidance, including the **American Heart Association's omega-3 advisory**. Overall, *Circulation* is a leading source for cutting-edge research and evidence-based recommendations in cardiovascular medicine.\",19\n2942,GUO QH,\"**GUO QH** is a researcher known for their involvement in studies related to masked hypertension subtypes and meta-analyses. They are also one of the authors of a randomized, placebo-controlled trial investigating the treatment of masked hypertension using a Chinese herbal formula. This study was published in *Circulation* in 2020, highlighting their contributions to cardiovascular research and traditional medicine applications in hypertension management.\",2\n2177,WHITE WB,\"Researcher who studied effects of blood pressure control on cerebrovascular outcomes>\nA researcher involved in a study on the effects of intensive versus standard blood pressure control on cerebrovascular outcomes>\",1\n2178,WAKEFIELD DB,\"Researcher who studied effects of blood pressure control on cerebrovascular outcomes>\nA researcher involved in a study on the effects of intensive versus standard blood pressure control on cerebrovascular outcomes>\",1\n2179,MOSCUFO N,\"Researcher who studied effects of blood pressure control on cerebrovascular outcomes>\nA researcher involved in a study on the effects of intensive versus standard blood pressure control on cerebrovascular outcomes>\",1\n3179,O'DONNELL CJ,\"Author of a study on hypertension and borderline isolated systolic hypertension risks, published in Circulation in 1997\"\"\",1\n3211,RAVINDRARAJAH R,,1\n3341,TURAN TN,\"Turan TN studied the relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis\"\"\",1\n3388,MAHINRAD S,,1\n3352,HAKALA JO,\"Researcher who studied cardiovascular risk factors and cognitive performance\"\"\",1\n3355,OISHI E,\"Researcher who studied blood pressure variability and dementia risk\"\"\",1\n2475,AMERICAN HEART ASSOCIATION,\"The **American Heart Association (AHA)** is a leading nonprofit organization in the United States dedicated to combating heart disease and stroke through research, education, and advocacy. It serves as a professional organization that publishes evidence-based guidelines for cardiovascular health, including the prevention, detection, evaluation, and management of high blood pressure in adults. The AHA also issues scientific statements and advisories on various topics, such as statin safety, omega-3 fatty acids for hypertriglyceridemia, and stroke prevention. Additionally, it conducts and disseminates research on hypertension and broader cardiovascular health, reinforcing its role as a key authority in the field. Through its multifaceted efforts, the American Heart Association strives to improve public health outcomes related to heart disease and stroke.\",16\n2487,WHELTON PK,\"Researcher involved in setting guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults\",2\n2488,CAREY RM,\"**CAREY RM** is a researcher specializing in hypertension and related cardiovascular conditions. They have been involved in studies focusing on resistant hypertension and have contributed to the development of clinical practice guidelines, including co-authoring guidelines for primary aldosteronism. Additionally, CAREY RM has played a role in setting broader guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults, demonstrating their expertise in the field of hypertension research and clinical practice.\",2\n4583,SKULAS-RAY AC,\"Co-author of a science advisory on omega-3 fatty acids for hypertriglyceridemia\"\"\",2\n2612,MACDONALD HV,\"Researcher analyzing resistance training for hypertension management\"\"\",1\n2743,AMERICAN STROKE ASSOCIATION,\"American Stroke Association is a professional organization involved in the development of stroke prevention guidelines.\"\"\",1\n3006,AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION,A professional organization dedicated to improving cardiovascular care through education and research,1\n3123,CALHOUN DA,A researcher involved in studies on resistant hypertension>,1\n3124,BAKRIS GL,\"BAKRIS GL is a researcher primarily associated with studies in the field of hypertension, with a focus on resistant hypertension and the relationship between body size and hypertension treatments. Their work encompasses investigating treatment approaches for challenging cases of hypertension, as well as exploring how body size factors influence therapeutic outcomes. As an author or contributor to research in these areas, BAKRIS GL contributes to advancing the understanding and management of hypertension through clinical and scientific studies.\",1\n4584,WILSON P,\"Co-author of a science advisory on omega-3 fatty acids for hypertriglyceridemia\"\"\",1\n4585,HARRIS WS,\"Co-author of a science advisory on omega-3 fatty acids for hypertriglyceridemia\"\"\",1\n2443,KANG YY,\"Researcher studying home vs. ambulatory blood pressure monitoring\"\"\",2\n2309,CHENG YB,\"CHENG YB is a researcher known for their contributions to cardiovascular studies, particularly in the fields of central and brachial blood pressure, masked hypertension, and arterial hemodynamics. They were involved in the IDCARS study, which focuses on central and brachial blood pressure, and have investigated subtypes of masked hypertension and their association with target organ damage. Additionally, CHENG YB was one of the authors of a 2020 randomized, placebo-controlled trial published in *Circulation*, which examined the efficacy of a Chinese herbal formula in treating masked hypertension. Their work also includes published studies on central hypertension and arterial hemodynamics, demonstrating a broad expertise in hypertension research and cardiovascular health.\",5\n2372,HYPERTENSION RESEARCH,\"Research and clinical studies on hypertension management and blood pressure monitoring\"\"\",4\n2484,BANGALORE S,\"**BANGALORE S** is a researcher or author primarily associated with studies related to diabetes and hypertension. Their work includes investigating optimal systolic blood pressure targets, particularly in the context of the SPRINT (Systolic Blood Pressure Intervention Trial) study. Bangalore S's research contributions focus on understanding and managing cardiovascular and metabolic conditions, with an emphasis on diabetes and hypertension. The descriptions consistently highlight their involvement in these areas, indicating a specialization in clinical research related to blood pressure management and associated chronic diseases.\",3\n3307,BMJ,\"The **BMJ (British Medical Journal)** is a leading medical journal that publishes a wide range of research and clinical guidelines across various health topics. It is recognized for its contributions to studies on hypertension, including home and online blood pressure management, as well as hypertension in pregnancy. The journal also covers research on cognitive function, stroke outcomes related to blood pressure, diabetes studies, and drug-mood disorder associations. In 2023, the BMJ published a notable trial examining the relationship between blood pressure and stroke outcomes. As a prominent source of medical research, the BMJ provides comprehensive insights into diverse health disciplines, ensuring high-quality, evidence-based information for healthcare professionals and researchers.\",6\n2872,BELLET M,\"Bellet M is one of the authors of the PRECISION study on aprocitentan for resistant hypertension\"\"\",3\n2873,WEBER MA,\"**Weber MA** is a researcher with a focus on hypertension and related treatments. He has been involved in several significant clinical trials, including the **TARGET BP I trial**, which investigates blood pressure management strategies. Additionally, Weber MA has contributed to studies examining the relationship between **body size and hypertension treatments**, highlighting his expertise in cardiovascular health. He is also one of the authors of the **PRECISION study**, which evaluates the efficacy of **aprocitentan** for treating **resistant hypertension**. His work demonstrates a broad engagement in hypertension research, spanning clinical trials and therapeutic investigations.\",5\n2900,PRECISION,\"PRECISION is a multicentre, blinded, randomized, parallel-group, phase 3 trial evaluating aprocitentan for resistant hypertension\"\"\",3\n2357,ZHANG DY,\"**ZHANG DY** is a researcher specializing in hypertension, with a focus on masked hypertension and its management. As a co-author of the **REACTION-ABP study**, ZHANG DY has contributed to research on hypertension treatment strategies. Additionally, they were one of the authors of a **randomized, placebo-controlled trial** published in *Circulation* in 2020, which investigated the efficacy of a **Chinese herbal formula** in treating masked hypertension. Their work also includes studying the **prevalence of masked hypertension in Chinese males**, as well as exploring its **subtypes and associated target organ damage**. Through these contributions, ZHANG DY has played a significant role in advancing the understanding and treatment of hypertension, particularly in the context of masked hypertension.\",3\n3856,HOME BP TRIAL,A randomized controlled trial on digital hypertension management published in BMJ,2\n2324,APARICIO LS,\"A researcher involved in studies on pulsatile blood pressure components and risk stratification\"\"\",2\n2474,AMERICAN COLLEGE OF CARDIOLOGY,\"The **American College of Cardiology (ACC)** is a professional medical society dedicated to cardiovascular care and research. It plays a key role in developing and disseminating clinical guidelines, including those for the prevention, detection, evaluation, and management of high blood pressure in adults. As a leading organization in the field, the ACC supports advancements in cardiovascular medicine through education, advocacy, and evidence-based practice.\",5\n2489,ARONOW WS,\"Researcher involved in setting guidelines for the prevention, detection, evaluation, and management of high blood pressure in adults\",2\n2391,SCHLAICH MP,\"SCHLAICH MP is a researcher who was involved in the May Measurement Month 2021 blood pressure screening campaign, an initiative aimed at raising awareness and improving hypertension detection globally. Additionally, SCHLAICH MP is one of the authors of the PRECISION study, which investigated the efficacy and safety of aprocitentan, a novel treatment for resistant hypertension. These contributions highlight SCHLAICH MP's active role in hypertension research, spanning both large-scale public health efforts and clinical trials focused on innovative therapeutic approaches.\",4\n3169,ABC-H,\"Ambulatory Blood Pressure Collaboration in Patients with Hypertension meta-analysis\"\"\",3\n2288,FRAMINGHAM HEART STUDY,\"The **Framingham Heart Study** is a long-term, ongoing cardiovascular cohort study that has significantly contributed to understanding blood pressure patterns, cardiovascular risks, and their relation to coronary heart disease. Initiated to track cardiovascular health over time, the study has investigated the association between blood pressure and coronary heart disease risk, particularly as participants age. A key publication from the study in *Circulation* (2001) examined this relationship in depth. Additionally, the study has assessed lifetime risks for developing congestive heart failure, providing critical insights into long-term cardiovascular health outcomes. Collectively, the Framingham Heart Study serves as a foundational resource for epidemiological research on heart disease and aging.\",4\n3358,SABAYAN B,\"Researcher who studied blood pressure variability and cognitive function\"\"\",1\n3664,PHARMACOLOGICAL REPORTS,\"Journal documenting drug interaction effects\"\"\",1\n3851,MCMANUS RJ,A researcher involved in the HOME BP trial using digital interventions for hypertension management,1\n2371,BEANEY T,\"Researcher involved in global blood pressure screening during the COVID-19 pandemic\"\"\",2\n2914,PATHAK A,Pathak A is a researcher involved in studies on alcohol-mediated renal denervation,3\n3443,JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,Leading cardiology journal publishing clinical guidelines>,1\n3502,AMERICAN DIABETES ASSOCIATION,\"The **American Diabetes Association (ADA)** is a professional organization dedicated to providing guidelines and position statements on diabetes and related conditions, including hypertension. It serves as a key resource for healthcare professionals and the public, offering evidence-based recommendations to manage and understand diabetes and its associated health issues. The ADA plays a significant role in advancing research, education, and advocacy efforts to improve diabetes care and prevention.\",4\n3503,DIABETES CARE,\"A journal publishing research on diabetes care\"\"\",2\n4610,CHINESE SOCIETY OF CARDIOLOGY OF CHINESE MEDICAL ASSOCIATION,\"The Chinese Society of Cardiology is a professional organization involved in cardiovascular disease prevention and research\"\"\",4\n4615,CHIN J CARDIOL,The *Chinese Journal of Cardiology (Chin J Cardiol)* is a prominent Chinese medical journal specializing in cardiology and cardiovascular research. It serves as a key platform for publishing clinical trial results and other significant cardiovascular studies conducted in China. The journal contributes to the dissemination of scientific knowledge and advancements in the field of cardiology within the country.,2\n2308,HUANG QF,\"HUANG QF is a researcher specializing in hypertension and blood pressure monitoring. They have contributed to multiple studies, including research on pulsatile blood pressure components and ambulatory blood pressure monitoring for diagnosing and managing hypertension. Additionally, HUANG QF has co-authored a randomized controlled trial on home blood pressure monitoring, demonstrating their expertise in both clinical and home-based blood pressure assessment methods. Their work spans various aspects of blood pressure research, emphasizing diagnostic accuracy and patient management.\",3\n2369,SHARMAN JE,\"Lead researcher on a clinical trial about blood pressure lowering in central hypertension\"\"\",1\n2370,WEBER T,\"Researcher who studied 24-hour central systolic blood pressure reference values\"\"\",1\n2388,MAY MEASUREMENT MONTH 2021,\"A global blood pressure screening campaign during the COVID-19 pandemic\"\"\",4\n2389,COVID-19 PANDEMIC,,1\n2431,BEANEYT,,1\n2390,WANGW,\"Researcher involved in the May Measurement Month 2021 blood pressure screening campaign\"\"\",1\n3168,J-HOP NOCTURNAL BLOOD PRESSURE STUDY,\"A study on cardiovascular event risks associated with masked nocturnal hypertension\"\"\",2\n3177,FRAMINGHAM,\"Location where the Framingham Heart Study was conducted\"\"\",1\n3501,DE BOER IH,\"A researcher involved in studies on diabetes and hypertension\"\"\",2\n4611,CARDIOVASCULAR DISEASE PREVENTION AND REHABILITATION COMMITTEE OF CHINESE ASSOCIATION OF REHABILITATION MEDICINE,\"This committee focuses on cardiovascular disease prevention and rehabilitation in China\"\"\",1\n4612,CARDIOVASCULAR DISEASE COMMITTEE OF CHINESE ASSOCIATION OF GERONTOLOGY AND GERIATRICS,\"This committee addresses cardiovascular disease in the context of aging populations\"\"\",1\n4639,CAI SY,Cai SY is a researcher who led a multicenter clinical trial on hybutimibe for hypercholesterolemia>,4\n4640,GU X,Gu X is a researcher involved in a clinical trial on hybutimibe and atorvastatin>,1\n4641,LIU PJ,Liu PJ is a researcher involved in a clinical trial on hybutimibe and atorvastatin>,1\n2729,FURBERGCD,\"FurbergCD is a researcher who contributed to studies on nifedipine and its effects on mortality in patients with coronary heart disease.\"\"\",3\n2730,PSATYBM,\"PsatyBM is a researcher involved in studies on nifedipine and cardiovascular health.\"\"\",1\n2731,MEYERJV,\"MeyerJV is a researcher who co-authored studies on nifedipine and its impact on coronary heart disease.\"\"\",1\n2926,EUROINTERVENTION,EuroIntervention published studies on alcohol-mediated renal denervation,1\n3002,SMITH SC JR,\"SMITH SC JR is a researcher specializing in cardiovascular studies, with a particular focus on developing guidelines for the secondary prevention of cardiovascular diseases. His work contributes to advancing knowledge and best practices in the field of cardiovascular health.\",3\n3024,BENJAMIN EJ,Researcher involved in cardiovascular disease prevention guidelines,1\n3025,BONOW RO,Researcher involved in cardiovascular disease prevention guidelines,1\n3176,SALLES GF,\"Researcher involved in ABC-H meta-analysis on nocturnal blood pressure\"\"\",1\n3508,DEBOERIH,deBoerIH is a researcher or author associated with studies on diabetes and hypertension>,2\n4648,CHINESE GERONTOLOGY SOCIETY,The Chinese Gerontology Society's Cardiovascular Committee authored a consensus on Xuezhikang capsule use>,2\n4652,XUEZHIKANG CONSENSUS GROUP,Expert group that established Chinese guidelines for Xuezhikang capsule use>,2\n2279,LLOYD-JONES DM,\"Lloyd-Jones DM is a researcher involved in the Framingham Heart Study, which examined lifetime risk for developing congestive heart failure.\"\"\",2\n2280,CONEN D,\"Conen D is a researcher who studied the influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women.\"\"\",1\n2374,MAY MEASUREMENT MONTH,\"Global blood pressure screening initiative during COVID-19 pandemic\"\"\",1\n3175,FUJIWARA T,\"Researcher involved in J-HOP nocturnal blood pressure study\"\"\",1\n4651,ZHONGHUA NEI KE ZA ZHI,Chinese Journal of Internal Medicine published the Xuezhikang consensus>,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n3360,BENETOS A,HYPERTENSION,Benetos A contributed to studies on hypertension management in older and frail patients,188\n2961,JAMA NETW OPEN,CIRC RES,Both publish research on hypertension and cardiovascular health,60\n3077,TARGET BP I,CIRCULATION,The TARGET BP I randomized clinical trial was published in Circulation.,22\n3080,CIRCULATION,GUO QH,Guo QH is one of the authors of a study published in Circulation.,21\n2453,CIRCULATION,WHITE WB,\"White WB published blood pressure research in Circulation\nWhite WB's research on blood pressure control was published in Circulation\",20\n2454,CIRCULATION,WAKEFIELD DB,\"Wakefield DB's research on blood pressure control was published in Circulation\nWakefield DB published blood pressure research in Circulation\",20\n2455,CIRCULATION,MOSCUFO N,\"Moscufo N's research on blood pressure control was published in Circulation\nMoscufo N published blood pressure research in Circulation\",20\n3334,CIRCULATION,O'DONNELL CJ,O'Donnell CJ's study was published in Circulation,20\n3368,CIRCULATION,RAVINDRARAJAH R,Circulation published research by Ravindrarajah R on blood pressure and mortality,20\n3448,CIRCULATION,TURAN TN,Turan TN published research in Circulation,20\n3458,CIRCULATION,MAHINRAD S,Published research on blood pressure and cognitive function in Circulation,20\n3459,CIRCULATION,HAKALA JO,Published research on cardiovascular risk factors in Circulation,20\n3460,CIRCULATION,OISHI E,Published research on blood pressure variability in Circulation,20\n2668,AMERICAN HEART ASSOCIATION,WHELTON PK,Whelton PK is a researcher involved in the American Heart Association,18\n3281,CAREY RM,AMERICAN HEART ASSOCIATION,Carey RM contributed to a scientific statement from the American Heart Association on resistant hypertension,18\n4455,SKULAS-RAY AC,AMERICAN HEART ASSOCIATION,Skulas-Ray AC co-authored a science advisory published by the American Heart Association,18\n2774,AMERICAN HEART ASSOCIATION,MACDONALD HV,MacDonald HV published resistance training research in this association's journal,17\n2886,AMERICAN HEART ASSOCIATION,AMERICAN STROKE ASSOCIATION,Both organizations jointly published guidelines for stroke prevention.,17\n3149,AMERICAN HEART ASSOCIATION,AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION,Collaborated on guidelines for secondary prevention of cardiovascular diseases,17\n3282,CALHOUN DA,AMERICAN HEART ASSOCIATION,Calhoun DA contributed to a scientific statement from the American Heart Association on resistant hypertension,17\n3283,BAKRIS GL,AMERICAN HEART ASSOCIATION,Bakris GL contributed to a scientific statement from the American Heart Association on resistant hypertension,17\n4457,WILSON P,AMERICAN HEART ASSOCIATION,Wilson P co-authored a science advisory published by the American Heart Association,17\n4458,HARRIS WS,AMERICAN HEART ASSOCIATION,Harris WS co-authored a science advisory published by the American Heart Association,17\n2637,KANG YY,LI Y,Co-authors of a study on home blood pressure monitoring,11\n2607,CHENG YB,HYPERTENSION RESEARCH,Cheng YB conducted research on central hypertension,9\n3563,BANGALORE S,BMJ,Bangalore S published research in BMJ journal,9\n3021,BELLET M,WEBER MA,Bellet M and Weber MA are co-authors of the PRECISION study,8\n3023,WEBER MA,PRECISION,Weber MA is an author of the PRECISION trial,8\n3300,ZHANG DY,CHENG YB,Cheng YB and Zhang DY collaborated on research about masked hypertension subtypes,8\n3826,BMJ,HOME BP TRIAL,The trial results were published in BMJ,8\n2557,CHENG YB,APARICIO LS,Cheng YB and Aparicio LS co-authored the IDCARS study,7\n2664,AMERICAN COLLEGE OF CARDIOLOGY,WHELTON PK,Whelton PK is a researcher involved in the American College of Cardiology,7\n2666,AMERICAN COLLEGE OF CARDIOLOGY,ARONOW WS,Aronow WS is a researcher involved in the American College of Cardiology,7\n3018,SCHLAICH MP,BELLET M,Schlaich MP and Bellet M are co-authors of the PRECISION study,7\n3020,SCHLAICH MP,PRECISION,Schlaich MP is an author of the PRECISION trial,7\n3328,ABC-H,FRAMINGHAM HEART STUDY,Both involve large-scale blood pressure research,7\n3461,BMJ,SABAYAN B,Published research on blood pressure variability in BMJ,7\n3700,PHARMACOLOGICAL REPORTS,BMJ,Both investigate drug-related effects,7\n3825,MCMANUS RJ,BMJ,McManus RJ published the HOME BP trial in BMJ,7\n2610,BEANEY T,HYPERTENSION RESEARCH,Beaney T researched global blood pressure screening during COVID-19,6\n3073,PATHAK A,TARGET BP I,Pathak A is a researcher involved in the TARGET BP I trial,6\n3518,AMERICAN COLLEGE OF CARDIOLOGY,JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,Official journal publishing ACC guidelines,6\n3556,AMERICAN DIABETES ASSOCIATION,DIABETES CARE,The association publishes the Diabetes Care journal,6\n4474,CHINESE SOCIETY OF CARDIOLOGY OF CHINESE MEDICAL ASSOCIATION,CHIN J CARDIOL,The society publishes in the Chinese Journal of Cardiology,6\n2556,HUANG QF,APARICIO LS,Huang QF and Aparicio LS co-authored a study on pulsatile blood pressure,5\n2608,SHARMAN JE,HYPERTENSION RESEARCH,Sharman JE led a clinical trial on central hypertension,5\n2609,WEBER T,HYPERTENSION RESEARCH,Weber T studied 24-hour central blood pressure patterns,5\n2625,MAY MEASUREMENT MONTH 2021,COVID-19 PANDEMIC,The blood pressure screening campaign was conducted during the COVID-19 pandemic,5\n2626,MAY MEASUREMENT MONTH 2021,BEANEYT,BeaneyT was a researcher in the May Measurement Month 2021 campaign,5\n2627,MAY MEASUREMENT MONTH 2021,WANGW,WangW was a researcher in the May Measurement Month 2021 campaign,5\n3326,J-HOP NOCTURNAL BLOOD PRESSURE STUDY,ABC-H,Both studies analyze nocturnal hypertension and its risks,5\n3330,FRAMINGHAM HEART STUDY,FRAMINGHAM,The study was conducted in Framingham,5\n3554,DE BOER IH,BANGALORE S,Co-authors of research on diabetes and hypertension,5\n4471,CHINESE SOCIETY OF CARDIOLOGY OF CHINESE MEDICAL ASSOCIATION,CARDIOVASCULAR DISEASE PREVENTION AND REHABILITATION COMMITTEE OF CHINESE ASSOCIATION OF REHABILITATION MEDICINE,Both organizations collaborated on the Chinese guideline for primary prevention of cardiovascular diseases,5\n4472,CHINESE SOCIETY OF CARDIOLOGY OF CHINESE MEDICAL ASSOCIATION,CARDIOVASCULAR DISEASE COMMITTEE OF CHINESE ASSOCIATION OF GERONTOLOGY AND GERIATRICS,Both organizations collaborated on the Chinese guideline for primary prevention of cardiovascular diseases,5\n4486,CAI SY,GU X,Cai SY and Gu X collaborated on a clinical trial for hypercholesterolemia,5\n4487,CAI SY,LIU PJ,Cai SY and Liu PJ collaborated on a clinical trial for hypercholesterolemia,5\n2870,FURBERGCD,PSATYBM,FurbergCD and PsatyBM co-authored research on nifedipine and coronary heart disease.,4\n2871,FURBERGCD,MEYERJV,FurbergCD and MeyerJV collaborated on studies related to nifedipine.,4\n3074,PATHAK A,EUROINTERVENTION,Pathak A published research in EuroIntervention,4\n3162,SMITH SC JR,BENJAMIN EJ,Co-authors on cardiovascular disease prevention guidelines,4\n3163,SMITH SC JR,BONOW RO,Co-authors on cardiovascular disease prevention guidelines,4\n3329,ABC-H,SALLES GF,Salles GF was involved in the ABC-H meta-analysis,4\n3562,DEBOERIH,DIABETES CARE,deBoerIH published research in Diabetes Care journal,4\n4497,CHINESE GERONTOLOGY SOCIETY,XUEZHIKANG CONSENSUS GROUP,The Society's cardiovascular committee organized the consensus group,4\n2525,LLOYD-JONES DM,CONEN D,Both researchers contributed to studies on blood pressure and heart-related conditions.,3\n2611,BEANEY T,MAY MEASUREMENT MONTH,Contributed to global blood pressure screening research,3\n3327,J-HOP NOCTURNAL BLOOD PRESSURE STUDY,FUJIWARA T,Fujiwara T was a researcher in the J-HOP study,3\n4498,ZHONGHUA NEI KE ZA ZHI,XUEZHIKANG CONSENSUS GROUP,The consensus group published guidelines in this journal,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_3d8464d921a22878388069e28d93984957ad32830aa0b6f123b89c04b1c7dd31_v2"}